Clinical Trial Update: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

View source ↗

Summary

Ongoing Phase 3 trial update examining long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in adults with moderate to severe hidradenitis s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Sonelokimab (sonelokimab)

Snippet

Sponsor: MoonLake Immunotherapeutics AG | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: ENROLLING_BY_INVITATION